Prev：Reprogramming of glycometabolism caused by low-level lead in vascular smooth muscle cells(ABP52230-3)
Next：Repurposing HIV protease inhibitors as senotherapeutic agents in cervical cancer: Dual targeting of CDK1/6-cell cycle arrest and p53/p21/p16 signaling axis.(A23420-2.2)
